Research News

FiercePharma
Bristol Myers' $4.1B Turning Point buy yields FDA approval for lung cancer drug Augtyro
Published Nov 16, 2023

Targeted Oncology
FDA Awards Breakthrough Therapy Designation to Novel HER2-Activating NSCLC Therapy
Published Feb 27, 2024

MDPI
Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer
Published Jan 25, 2024

MDPI
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001
Published Dec 27, 2023

CURE
ROS1-Positive NSCLC Represents a Targetable Mutation for New Therapies
Published Dec 21, 2023

OncLive
Repotrectinib May Serve as a New Standard of Care Across Treatment Lines in ROS1+ NSCLC
Published Dec 17, 2023

Medscape
FDA Approves Repotrectinib for ROS1-Positive NSCLC
Published Nov 16, 2023

OncLive
Approach to Treating Patients with NSCLC and RET Fusions
Published Oct 3, 2023

OncLive
Treating MET Exon 14 NSCLC
Published Oct 3, 2023

Get Connected

Join Us for the Rare Mutations & Fusions Virtual Meetup
It’s the easy way to build your community. On the first Wednesday of each month, you can connect with others who understand what it’s like to live with rare subtypes of lung cancer. The next Rare Mutations & Fusions Virtual Meetup is happening on Wednesday, April 3, 2024, at 3 pm ET. Register for this virtual meetup to get a confirmation email with details about how to join the virtual meeting. Can’t make it? Don’t worry, there’s a full list of virtual meetups to fit your schedule.

HOPE Summit – Families Are Welcome
Join us in Atlanta for this free conference May 3-5, 2024. This family-friendly event features inspirational speakers and lung cancer experts to answer questions and offer tips for addressing the everyday issues that come up for people living with lung cancer. Don’t miss this opportunity to hear directly from lung cancer survivors and caregivers who have a firsthand view of what it is like to survive and thrive after a lung cancer diagnosis. Because lung cancer affects the whole family, we will also have special activities for kids and caregivers. Learn more.

Have You Seen?

What Are the Phases of Clinical Trials?
Lung cancer clinical trials are carefully designed research studies to evaluate and learn more about new drugs and treatments. Clinical trials are often described as phase 1, 2, 3, or 4. These phases can help us understand the benefits and drawbacks of participating in a particular clinical trial. Join Marissa Fors, an oncology social worker with CancerCare, for a brief explanation of the phases of clinical trials. Watch it here.

Get Smart About Lung Cancer
Over the past decade, we’ve seen an explosion in new treatment options for people with lung cancer. But it can be difficult to keep track of all the new drug improvements and scientific advancements. Check out this masterclass to get smart about lung cancer. Read it here.

Helpful Apps for People Living with Lung Cancer
As smartphones have become a larger part of our lives, we have an opportunity to use technology to help us manage a cancer diagnosis. Take a look at this list of helpful apps to consider when managing a lung cancer diagnosis. Read it here.

…and so much more at the Rare Mutations & Fusions Patient Gateway.

If you were forwarded this email and you’d like to subscribe to this newsletter, you can sign up here.

If you need further assistance along your lung cancer journey, please email us at support@lungevity.org. Our team is always here to assist you.